IISc develops compound boosting antibody production against cancer cells

Summary: Researchers at the Indian Institute of Science (IISc) have developed a synthetic compound that boosts antibody production against cancer cells by targeting a protein in the blood and traveling to the lymph nodes. This innovative approach opens new possibilities for cancer vaccine development. The compound, utilizing a truncated carbohydrate and serum albumin, showed promising results in mice models, indicating potential for future clinical trials targeting various cancers.

Full article